Validation and integration of gene-expression signatures in cancer

References

• Goldhirsch A, Wood C, Gelber RD et al. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J. Clin. Oncol.21, 3357–3365 (2003).
   PubMed Web of Science ®Google Scholar
• Eifel P, Axelson JA, Costa J et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer. J. Natl Cancer Inst.93, 979–989 (2001).
   PubMed Web of Science ®Google Scholar
• Van’t Veer LJ, Dai H, van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature415, 530–536 (2002).
   PubMed Web of Science ®Google Scholar
• Wang Y, Klijn JG, Zhang Y et al. Gene expression profiles to predict distant metastasis of lymph node negative primary breast cancer. Lancet365, 671–679 (2005).
   PubMed Web of Science ®Google Scholar
• Foekens JA, Atkins D, Zhang Y et al. Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J. Clin. Oncol.24, 1665–1671 (2006).
   PubMed Web of Science ®Google Scholar
• Desmedt C, Piette F, Loi S et al. TRANSBIG Consortium. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin. Cancer Res.13, 3207–3214 (2007).
   PubMed Web of Science ®Google Scholar
• Paik S, Shak S, Tang G et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med.351, 2817–2826 (2004).
   PubMed Web of Science ®Google Scholar
• Yu JX, Sieuwerts AM, Zhang Y et al. Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer. BMC Cancer7, 182 (2007).
   PubMed Web of Science ®Google Scholar
• Goeman JJ, Buhlmann P. Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics23(8), 980–987 (2007).
   PubMed Web of Science ®Google Scholar
• Adler AS, Lin M, Horlings H et al. Genetic regulators of large-scale transcriptional signatures in cancer. Nat. Genet.38, 421–430 (2006).
   PubMed Web of Science ®Google Scholar
• Sun Y, Goodison S, Li J et al. Improved breast cancer prognosis through the combination of clinical and genetic markers. Bioinformatics23(1), 30–37 (2007).
   PubMed Web of Science ®Google Scholar
• Lanfear DE, McLeod HL. Pharmacogenetics: using DNA to optimize drug therapy. Am. Fam. Physician76, 1179–1182 (2007).
   PubMed Web of Science ®Google Scholar
• Miller LD, Smeds J, George J et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl Acad. Sci. USA102, 13550–13555 (2005).
   PubMed Web of Science ®Google Scholar
• Troester MA, Herschkowitz JI, Oh DS et al. Gene expression patterns associated with p53 status in breast cancer. BMC Cancer6, 276 (2006).
   PubMed Web of Science ®Google Scholar
• Chin K, DeVries S, Fridlyand J et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell10, 529–541 (2005).
   Google Scholar
• Allegra CJ, Paik S, Colangelo LH et al. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes’ B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J. Clin. Oncol.21, 241–250 (2003).
   PubMed Web of Science ®Google Scholar
• Barrier A, Boelle PY, Roser F et al. Stage II colon cancer prognosis prediction by tumor gene expression profiling. J. Clin. Oncol.24, 4685–4691 (2006).
   PubMed Web of Science ®Google Scholar
• Arango D, Laiho P, Kokko A et al. Gene-expression profiling predicts recurrence in Dukes’ C colorectal cancer. Gastroenterology129(3), 874–884 (2005).
   PubMed Web of Science ®Google Scholar
• Grade M, Hörmann P, Becker S et al. Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. Cancer Res.67, 41–56 (2007).
   PubMedGoogle Scholar
• Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J. Natl Cancer Inst.97, 219–225 (2005).
   PubMed Web of Science ®Google Scholar
• Kohn KW, Aladjem MI, Kim S et al. Depicting combinatorial complexity with the molecular interaction map notation. Mol. Syst. Biol.2, 51 (2006).
   Google Scholar
• Stephenson AJ, Scardino PT, Eastham JA et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J. Natl Cancer Inst.98, 715–717 (2006).
   PubMed Web of Science ®Google Scholar
• West M, Ginsburg GS, Huang AT et al. Embracing the complexity of genomic data for personalized medicine. Genome Res.16, 559–566 (2006).
   PubMed Web of Science ®Google Scholar